Publications by authors named "Javier Anguita"

Claim this Profile
P
Predictive biomarkers validation of CD3 cell apheresis yield in CAR-T manufacturing for diffuse large B-cell lymphoma: a machine learning approach.
Diego Carbonell, Alejandra Rodríguez-Sosa, Leticia Gómez-Serrano, Ana Pérez-Corral, Gloria Ruano, Javier Anguita

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
34° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular (SETS), Alicante, 5-7 junio 2025.
Cristina Arbona, Javier Anguita, Lola Fernández, Ángel Giménez, Rosa Goterris

Blood Transfus· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor copies in cell-free DNA predict relapse in aggressive B-cell lymphoma patients treated with CAR T-cell therapy.
Ismael de la Iglesia-San Sebastián, Miguel López-Esteban, Mariana Bastos-Oreiro, Sara Fernández de Córdoba-Oñate, Maravillas Gutierrez, Javier Anguita

Br J Haematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of predictive models including polymorphisms in cytokines genes and clinical variables associated with post-transplant complications after identical HLA-allogeneic stem cell transplantation.
Paula Muñiz, María Martínez-García, Rebeca Bailén, María Chicano, Gillen Oarbeascoa, Javier Anguita

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advantages of high cell concentration prior to cryopreservation of initial leukapheresis in CAR-T cell therapy.
Diego Carbonell, Silvia Monsalvo, Eva Catalá, Ana Pérez-Corral, Carolina Villegas, Javier Anguita

Blood Transfus· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital PCR Improves Sensitivity and Quantification in Monitoring CAR-T Cells in B Cell Lymphoma Patients.
Ismael de la Iglesia-San Sebastián, Diego Carbonell, Mariana Bastos-Oreiro, Ana Pérez-Corral, Rebeca Bailén, Javier Anguita

Transplant Cell Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor graft function after haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Ignacio Gómez-Centurión, Reyes Maria Martin Rojas, Rebeca Bailén, Cristina Muñoz, Santiago Sabell, Javier Anguita

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Rebeca Bailén, Raquel Alenda, Beatriz Herruzo-Delgado, Cynthia Acosta-Fleitas, Ana Vallés, Javier Anguita

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic CD34-selected stem cell boost as salvage treatment of life-threatening infection and severe cytopenias after CAR-T cell therapy.
Pablo Silva de Tena, Rebeca Bailén, Gillen Oarbeascoa, Ignacio Gómez-Centurión, Ana Pérez-Corral, Javier Anguita

Transfusion· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.
Paula Muñiz, Cristina Andrés-Zayas, Diego Carbonell, María Chicano, Rebeca Bailén, Javier Anguita

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
-
-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia.
Diego Carbonell, María Chicano, Alfonso J Cardero, Ignacio Gómez-Centurión, Rebeca Bailén, Javier Anguita

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical grade production of IL-15 stimulated NK cells for early infusion in adult AML patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Eva Rubio-Azpeitia, Ana Maria Pérez-Corral, Nieves Dorado-Herrero, Silvia Monsalvo, Gonzalo Pérez-Balsera, Javier Anguita

Transfusion· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Ignacio Gómez-Centurión, Gillen Oarbeascoa, María Carmen García, María Carmen López Fresneña, María Josefa Martínez Carreño, Javier Anguita

Int J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel.
Reyes Maria Martín-Rojas, Ignacio Gómez-Centurión, Rebeca Bailén, Mariana Bastos, Francisco Diaz-Crespo, Javier Anguita

Clin Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
Rebeca Bailén, José Luis Vicario, Laura Solán, Irene Sánchez-Vadillo, Pilar Herrera, Javier Anguita

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide.
Paula Muñiz, Mi Kwon, Diego Carbonell, María Chicano, Rebeca Bailén, Javier Anguita

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
Isabel Regalado-Artamendi, Ana M Pérez-Corral, Marina García-Morín, Elena Cela, Cristina Beléndez, Javier Anguita

Blood Transfus· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elafin as a Predictive Biomarker of Acute Skin Graft--Host Disease After Haploidentical Stem Cell Transplantation Using Post-Transplant High-Dose Cyclophosphamide.
Laura Solán, Diego Carbonell, Paula Muñiz, Nieves Dorado, Elena Landete, Javier Anguita

Front Immunol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next Generation Cytogenetics in Myeloid Hematological Neoplasms: Detection of CNVs and Translocations.
María Chicano, Diego Carbonell, Julia Suárez-González, Sergio Lois, Mercedes Ballesteros-Culebras, Javier Anguita

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic biomarkers identify a subgroup of high-risk patients within low-risk -mutated acute myeloid leukemia.
Diego Carbonell, Julia Suárez-González, María Chicano, Cristina Andrés-Zayas, Miriam Díez-Díez, Javier Anguita

Leuk Lymphoma· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation.
Rebeca Bailén, Mi Kwon, María Jesús Pascual-Cascón, Christelle Ferrà, Jaime Sanz, Javier Anguita

Ann Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
Ignacio Gómez-Centurión, Rebeca Bailén, Gillen Oarbeascoa, Cristina Muñoz, Arturo Álvarez Luque, Javier Anguita

Biol Blood Marrow Transplant· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide.
Laura Solán, Elena Landete, Rebeca Bailén, Nieves Dorado, Gillen Oarbeascoa, Javier Anguita

Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.
Mariana Bastos-Oreiro, Pascual Balsalobre, Pilar Miralles, Juan Berenguer, Nieves Dorado, Javier Anguita

Bone Marrow Transplant· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation.
Mi Kwon, Rebeca Bailén, María Jesús Pascual-Cascón, Ana Isabel Gallardo-Morillo, Abel García Sola, Javier Anguita

Blood Adv· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis